Sign Out
Hypersensitivity to the active substance or any of the excipients listed in Description.
Aortic or mitral valvular heart disease.
Pulmonary arterial hypertension.
Within 14 days of the administration of monoamine oxidase inhibitors due to an increased risk of serotonin syndrome.
